Avian Gastric Yeast, also known as megabacteriosis, is a fungal infection of the digestive system caused by the organism Macrorhabdus ornithogaster, which affects budgerigars and other small birds. This condition has been recognized in aviculture for decades under various names, including going light syndrome in budgerigars, reflecting the characteristic weight loss and wasting that occurs in affected birds. Budgerigars are among the most commonly affected species, with the disease considered endemic in many breeding populations worldwide. The organism colonizes the proventriculus and ventriculus, disrupting normal digestive function and nutrient absorption, leading to progressive weight loss despite maintained or increased appetite. The condition can range from subclinical carrier states to severe, life-threatening illness.
The causative agent, Macrorhabdus ornithogaster, was long classified as a bacterium due to its large, rod-shaped appearance, leading to the name megabacteria. However, molecular studies have definitively identified it as a yeast, leading to the more accurate name avian gastric yeast. The organism is unusual among yeasts for its large size and elongated shape. It colonizes the isthmus between the proventriculus and ventriculus, where it attaches to the mucosal surface and can cause inflammation, ulceration, and disruption of normal gastric function. The organism produces substances that alter the gastric pH and interfere with the digestive process. Transmission occurs through fecal-oral contact, with the organism shed in droppings and ingested by susceptible birds.
The impact of avian gastric yeast on affected budgerigars can range from minimal in subclinical carriers to severe in birds with active disease. The hallmark of clinical megabacteriosis is progressive weight loss despite good appetite, as affected birds cannot properly digest and absorb nutrients. Regurgitation of undigested or partially digested seeds is common. Chronic infection leads to muscle wasting, weakness, and reduced activity. The condition is particularly devastating in breeding colonies, where it can spread rapidly and affect multiple birds. Young birds and those stressed by breeding, molting, or environmental factors are at increased risk of developing clinical disease from subclinical infection. Without treatment, severely affected birds may become emaciated and die.
Megabacteriosis is treatable with antifungal medications, and many birds can recover fully with appropriate therapy. Amphotericin B has traditionally been the mainstay of treatment, administered orally to act directly on the organism in the gastrointestinal tract. Treatment must be continued long enough to eliminate the infection, and relapses can occur if treatment is stopped too soon. Dietary modifications and stress reduction support recovery. Early detection and treatment improve outcomes significantly, making awareness of the condition important for budgerigar owners. Regular veterinary care, including fecal examination for the organism, helps identify infections before severe clinical signs develop. Working with an avian veterinarian ensures proper diagnosis and appropriate treatment protocols.
